Time Course of Tissue Plasminogen Activator–Induced Recanalization in Acute Cardioembolic Stroke
- 1 December 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (12) , 2821-2827
- https://doi.org/10.1161/hs1201.99821
Abstract
Background and Purpose — The relationship between arterial recanalization, infarct size, and outcome in patients treated with intravenous thrombolytics remains unclear. Therefore, we aimed to determine the time course of recombinant tissue plasminogen activator (rtPA)-induced recanalization in patients with cardioembolic stroke treated Methods — We prospectively studied 72 patients with an acute cardioembolic stroke in the middle cerebral artery territory: 24 treated with rtPA at Results — Rate of 6-hour recanalization was higher ( P P 3 in rtPA patients and 124.8±81.6 cm 3 in controls ( P P P =0.037) became functionally independent (modified Rankin Scale score ≤2). A close relationship ( P =0.002) existed between modified Rankin Scale score at 3 months and time to reperfusion. In addition, clinical outcome was associated strongly ( P =0.001) with degree of 6-hour recanalization. Logistic regression analysis identified National Institutes of Health Stroke Scale score P =0.001) and early recanalization (odds ratio 23.4, 95% confidence interval 5.4 to 96, P =0.001) as independent predictors of functional independence at 3 months. Conclusions — Intravenous rtPA is associated with early recanalization, which leads to lower infarct size and better clinical outcome. Early recanalization is a powerful independent predictor of functional independence at 3 months.Keywords
This publication has 20 references indexed in Scilit:
- Early Postischemic Hyperperfusion: Pathophysiologic Insights from Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1999
- Clinical Recovery from Acute Ischemic Stroke after Early Reperfusion of the Brain with Intravenous ThrombolysisNew England Journal of Medicine, 1999
- Tissue at Risk of Infarction Rescued by Early Reperfusion: A Positron Emission Tomography Study in Systemic Recombinant Tissue Plasminogen Activator Thrombolysis of Acute StrokeJournal of Cerebral Blood Flow & Metabolism, 1998
- Should Thrombolytic Therapy Be the First-Line Treatment for Acute Ischemic Stroke?New England Journal of Medicine, 1997
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Early spontaneous hyperperfusion after strokeBrain, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992
- Thrombolytic Agents in the Treatment of StrokeClinical Neuropharmacology, 1990
- Thresholds of focal cerebral ischemia in awake monkeysJournal of Neurosurgery, 1981